Synopsis
Synopsis
0
JDMF
0
KDMF
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 1-(diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine
2. Cinarizina Inkey
3. Cinarizina Ratiopharm
4. Cinarizine
5. Cinazire
6. Cinna
7. Cinnarizin Al
8. Cinnarizin Ratiopharm
9. Cinnarizin Siegfried
10. Cinnarizin Von Ct
11. Cinnarizin-ratiopharm
12. Cinnarizine L Tartrate
13. Cinnarizine L-tartrate
14. Cinnarizine L-tartrate (1:1)
15. Cinnarizine, (e)-isomer
16. Cinnarizine, Dihydrochloride
17. Cinnipirine
18. Cisaken
19. Dihydrochloride Cinnarizine
20. Dimitronal
21. L-tartrate, Cinnarizine
22. R 516
23. R-516
24. R516
25. Stugeron
26. Stugeron Forte
27. Von Ct, Cinnarizin
1. 298-57-7
2. Stugeron
3. Stutgin
4. Cinarizine
5. Dimitronal
6. Stutgeron
7. Dimitron
8. Folcodal
9. Labyrin
10. Midronal
11. Mitronal
12. Glanil
13. Sepan
14. Cinazyn
15. Aplactan
16. Cinnageron
17. Lazeta
18. Marisan
19. Toliman
20. Cinaperazine
21. Cinnipirine
22. Cerepar
23. Cinnarizinum
24. Cerebolan
25. Cinarizina
26. Cinnacet
27. Corathiem
28. Giganten
29. Hilactan
30. Katoseran
31. Processine
32. Sedatromin
33. Siptazin
34. Spaderizine
35. Aplexal
36. Artate
37. Carecin
38. Denapol
39. Ixertol
40. Olamin
41. Eglen
42. 1-benzhydryl-4-cinnamylpiperazine
43. 16699-20-0
44. R 516
45. 1-cinnamyl-4-(diphenylmethyl)piperazine
46. R 1575
47. 516 Md
48. Piperazine, 1-(diphenylmethyl)-4-(3-phenyl-2-propenyl)-
49. 1-benzhydryl-4-cinnamylpiperazin
50. 1-benzhydryl-4-[(e)-3-phenylprop-2-enyl]piperazine
51. Stunarone
52. 1-(diphenylmethyl)-4-[(2e)-3-phenylprop-2-en-1-yl]piperazine
53. (e)-1-benzhydryl-4-cinnamylpiperazine
54. 1-(diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine
55. R-516
56. 1-trans-cinnamyl-4-diphenylmethylpiperazine
57. 1-benzhydryl-4-[(e)-cinnamyl]piperazine
58. Chembl43064
59. Mls000028498
60. 3di2e1x18l
61. Piperazine, 1-cinnamyl-4-(diphenylmethyl)-
62. Chebi:31403
63. R-1575
64. 516-md
65. Nsc-758400
66. 1-(diphenylmethyl)-4-(3-phenyl-2-propen-1-yl)piperazine
67. Libotasin
68. Senoger
69. Smr000058307
70. Votegol
71. Zepamol
72. Cero-aterin
73. Dsstox_cid_2821
74. Dsstox_rid_76744
75. Dsstox_gsid_22821
76. Cinarizina [inn-spanish]
77. Cinnarizinum [inn-latin]
78. Apotomin
79. Stonoron
80. Cinnarizine [usan:inn:ban:jan]
81. Sr-01000003093
82. Einecs 206-064-8
83. Md 516
84. Brn 0626121
85. Unii-3di2e1x18l
86. Cinnarizine (jan/usan/inn)
87. 1-cinnamyl-4-diphenylmethylpiperazine
88. N-benzhydryl-n'-cinnamylpiperazine
89. Ncgc00015246-02
90. 1185242-27-6
91. Cas-298-57-7
92. Cinnarizine, Powder
93. Prestwick_115
94. Mfcd00056037
95. Piperazine, (e)-
96. Cinnarizine [mi]
97. Opera_id_1776
98. Prestwick2_000278
99. Prestwick3_000278
100. Cinnarizine [inn]
101. Cinnarizine [jan]
102. 1-(diphenylmethyl)-4-(3-phenylprop-2-enyl)piperazine
103. Cinnarizine [usan]
104. C 5270
105. Cinnarizine [mart.]
106. Lopac0_000314
107. Schembl44957
108. Schembl44958
109. Bspbio_000156
110. Cinnarizine [who-dd]
111. Mls001148649
112. Mls002207295
113. Mls002222167
114. Bpbio1_000172
115. Gtpl9072
116. 1-(diphenylmethyl)-4-(3-phenyl-2-propenyl)-piperazine
117. Cid_1547484
118. Cinnarizine [ep Impurity]
119. Dtxsid80859311
120. Chebi:131176
121. 4-((2e)-3-phenylprop-2-enyl)-1-(diphenylmethyl)piperazine
122. Cinnarizine [ep Monograph]
123. Hms1568h18
124. Hms2095h18
125. Hms2234b20
126. Hms3260p10
127. Hms3712h18
128. Hms3885f20
129. Component Of Emesazine (salt/mix)
130. Hy-b1090
131. Tox21_110109
132. Tox21_500314
133. Bdbm50017657
134. Nsc290687
135. Nsc771642
136. Stk216257
137. Zinc19632891
138. Akos002134299
139. Stugeron
140. Dimitronal
141. Stutgin
142. Cinarizine
143. Tox21_110109_1
144. Ccg-204409
145. Cs-4656
146. Ks-5155
147. Lp00314
148. Nsc 758400
149. Nsc-290687
150. Nsc-771642
151. Sdccgsbi-0050302.p002
152. Qtl1_000023
153. Ncgc00018187-03
154. Ncgc00018187-04
155. Ncgc00018187-05
156. Ncgc00018187-06
157. Ncgc00018187-07
158. Ncgc00018187-09
159. Ncgc00018187-14
160. Ncgc00021488-03
161. Ncgc00021488-04
162. Ncgc00021488-05
163. Ncgc00260999-01
164. Bc167081
165. Ls-15144
166. Eu-0100314
167. S4727
168. A16455
169. D01295
170. D89561
171. 298c577
172. A820077
173. L001227
174. Q775073
175. 1-benzhydryl-4-[3-phenyl-2-propenyl]piperazine #
176. Sr-01000003093-2
177. Sr-01000003093-6
178. W-106970
179. W-110442
180. 1-benzhydryl-4-[(2e)-3-phenylprop-2-enyl]piperazine
181. Brd-k07220430-001-03-6
182. Brd-k74927006-001-01-2
183. 1-[di(phenyl)methyl]-4-(3-phenylprop-2-enyl)piperazine
184. 1-(diphenylmethyl)-4-(3-phenylprop-2-en-1-yl)piperazine
185. Cinnarizine, European Pharmacopoeia (ep) Reference Standard
186. Piperazine, 1-(diphenylmethyl)-4-(3-phenyl-2-propen-1-yl)-
187. N90
| Molecular Weight | 368.5 g/mol |
|---|---|
| Molecular Formula | C26H28N2 |
| XLogP3 | 5.8 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 6 |
| Exact Mass | 368.225248902 g/mol |
| Monoisotopic Mass | 368.225248902 g/mol |
| Topological Polar Surface Area | 6.5 Ų |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 429 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Calcium Channel Blockers
A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)
Histamine H1 Antagonists
Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)
N - Nervous system
N07 - Other nervous system drugs
N07C - Antivertigo preparations
N07CA - Antivertigo preparations
N07CA02 - Cinnarizine
Cinnarizine has known human metabolites that include 1-Benzhydrylpiperazine, 1-Cinnamylpiperazine, 4-{3-[4-(diphenylmethyl)piperazin-1-yl]prop-1-en-1-yl}phenol, 4-{phenyl[4-(3-phenylprop-2-en-1-yl)piperazin-1-yl]methyl}phenol, Benzophenone, and Cinnamaldehyde.
S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Cinnarizine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cinnarizine, including repackagers and relabelers. The FDA regulates Cinnarizine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cinnarizine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cinnarizine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cinnarizine supplier is an individual or a company that provides Cinnarizine active pharmaceutical ingredient (API) or Cinnarizine finished formulations upon request. The Cinnarizine suppliers may include Cinnarizine API manufacturers, exporters, distributors and traders.
click here to find a list of Cinnarizine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Cinnarizine DMF (Drug Master File) is a document detailing the whole manufacturing process of Cinnarizine active pharmaceutical ingredient (API) in detail. Different forms of Cinnarizine DMFs exist exist since differing nations have different regulations, such as Cinnarizine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Cinnarizine DMF submitted to regulatory agencies in the US is known as a USDMF. Cinnarizine USDMF includes data on Cinnarizine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cinnarizine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Cinnarizine suppliers with USDMF on PharmaCompass.
A Cinnarizine CEP of the European Pharmacopoeia monograph is often referred to as a Cinnarizine Certificate of Suitability (COS). The purpose of a Cinnarizine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Cinnarizine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Cinnarizine to their clients by showing that a Cinnarizine CEP has been issued for it. The manufacturer submits a Cinnarizine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Cinnarizine CEP holder for the record. Additionally, the data presented in the Cinnarizine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Cinnarizine DMF.
A Cinnarizine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Cinnarizine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Cinnarizine suppliers with CEP (COS) on PharmaCompass.
A Cinnarizine written confirmation (Cinnarizine WC) is an official document issued by a regulatory agency to a Cinnarizine manufacturer, verifying that the manufacturing facility of a Cinnarizine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Cinnarizine APIs or Cinnarizine finished pharmaceutical products to another nation, regulatory agencies frequently require a Cinnarizine WC (written confirmation) as part of the regulatory process.
click here to find a list of Cinnarizine suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cinnarizine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Cinnarizine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Cinnarizine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Cinnarizine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cinnarizine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Cinnarizine suppliers with NDC on PharmaCompass.
Cinnarizine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cinnarizine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cinnarizine GMP manufacturer or Cinnarizine GMP API supplier for your needs.
A Cinnarizine CoA (Certificate of Analysis) is a formal document that attests to Cinnarizine's compliance with Cinnarizine specifications and serves as a tool for batch-level quality control.
Cinnarizine CoA mostly includes findings from lab analyses of a specific batch. For each Cinnarizine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cinnarizine may be tested according to a variety of international standards, such as European Pharmacopoeia (Cinnarizine EP), Cinnarizine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cinnarizine USP).
LOOKING FOR A SUPPLIER?
